Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

802 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N. Sibbing D, et al. J Am Coll Cardiol. 2009 Mar 10;53(10):849-56. doi: 10.1016/j.jacc.2008.11.030. J Am Coll Cardiol. 2009. PMID: 19264241 Clinical Trial.
A point-of-care assay with similar predictive power would be of great value. METHODS: Between February 2007 and April 2008, a total of 1,608 consecutive patients with coronary artery disease and planned drug-eluting stent implantation were enrolled. ...The ADP-induc
A point-of-care assay with similar predictive power would be of great value. METHODS: Between February 2007 and April 2008, a
Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation. A randomized study.
von Hoch F, Neumann FJ, Theiss W, Kastrati A, Schömig A. von Hoch F, et al. Eur Heart J. 1995 May;16(5):640-6. doi: 10.1093/oxfordjournals.eurheartj.a060967. Eur Heart J. 1995. PMID: 7588895 Clinical Trial.
A vascular haemostasis device has recently been introduced that allows percutaneous implantation of collagen plugs for haemostatic sealing of puncture sites even under full anticoagulation. ...Seventy-eight patients with coronary stenting and 231 patients with PTCA were in
A vascular haemostasis device has recently been introduced that allows percutaneous implantation of collagen plugs for haemostatic se
Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure.
Schömig A, Kastrati A, Mudra H, Blasini R, Schühlen H, Klauss V, Richardt G, Neumann FJ. Schömig A, et al. Circulation. 1994 Dec;90(6):2716-24. doi: 10.1161/01.cir.90.6.2716. Circulation. 1994. PMID: 7994813
As part of an initial policy, stenting was intended as a bridge to nonemergency bypass surgery in 26 patients. In 301 patients for whom stenting was intended as permanent treatment, early clinical course (first 4 weeks) was characterized by a 1.3% cardiac mortality …
As part of an initial policy, stenting was intended as a bridge to nonemergency bypass surgery in 26 patients. In 301 patients for wh …
Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment.
Schömig A, Kastrati A, Dietz R, Rauch B, Neumann FJ, Katus HH, Busch U. Schömig A, et al. J Am Coll Cardiol. 1994 Apr;23(5):1053-60. doi: 10.1016/0735-1097(94)90589-4. J Am Coll Cardiol. 1994. PMID: 8144767
In-stent balloon redilation in patients with restenosis is associated with excellent short-term results and a restenosis rate not different from that reported for nonstented vessels....
In-stent balloon redilation in patients with restenosis is associated with excellent short-term results and a restenosis rate not dif …
Time course of restenosis during the first year after emergency coronary stenting.
Kastrati A, Schömig A, Dietz R, Neumann FJ, Richardt G. Kastrati A, et al. Circulation. 1993 May;87(5):1498-505. doi: 10.1161/01.cir.87.5.1498. Circulation. 1993. PMID: 8491004
The incidence of restenosis (defined as a diameter stenosis > or = 50%) was 22.0% at 3 months, 31.9% at 6 months, and 33.2% at 12 months. ...Coronary lumen dimensions demonstrated a peak change at 3 months and remained mostly stable after the first 6 months....
The incidence of restenosis (defined as a diameter stenosis > or = 50%) was 22.0% at 3 months, 31.9% at 6 months, and 33.2% at 12 …
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
Schömig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K. Schömig A, et al. N Engl J Med. 1996 Apr 25;334(17):1084-9. doi: 10.1056/NEJM199604253341702. N Engl J Med. 1996. PMID: 8598866 Clinical Trial.
The primary cardiac end point was a composite measure reflecting death from cardiac causes or the occurrence of myocardial infarction, aortocoronary bypass surgery, or repeat angioplasty. ...With antiplatelet therapy, there was an 82 percent lower risk of myocardial infarc …
The primary cardiac end point was a composite measure reflecting death from cardiac causes or the occurrence of myocardial infarction …
Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.
Schömig A, Neumann FJ, Walter H, Schühlen H, Hadamitzky M, Zitzmann-Roth EM, Dirschinger J, Hausleiter J, Blasini R, Schmitt C, Alt E, Kastrati A. Schömig A, et al. J Am Coll Cardiol. 1997 Jan;29(1):28-34. doi: 10.1016/s0735-1097(96)00450-0. J Am Coll Cardiol. 1997. PMID: 8996291 Clinical Trial.
The objective of this study was to compare early and late clinical and angiographic outcome in a subgroup of patients with stent placement for acute myocardial infarction. ...RESULTS: During the first 30 days after stenting, patients with antiplatelet therapy had a
The objective of this study was to compare early and late clinical and angiographic outcome in a subgroup of patients with stent plac …
Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
Kastrati A, Schühlen H, Hausleiter J, Walter H, Zitzmann-Roth E, Hadamitzky M, Elezi S, Ulm K, Dirschinger J, Neumann FJ, Schömig A. Kastrati A, et al. Circulation. 1997 Jul 15;96(2):462-7. Circulation. 1997. PMID: 9244213 Clinical Trial.
BACKGROUND: Platelets and mural thrombus at the lesion site may play a key role in initiating the restenosis process after coronary interventions. The ISAR Trial provides a comparison of the outcomes of patients randomized to two different antithrombotic regimens ad …
BACKGROUND: Platelets and mural thrombus at the lesion site may play a key role in initiating the restenosis process after coronary i …
Predictive factors of restenosis after coronary stent placement.
Kastrati A, Schömig A, Elezi S, Schühlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ. Kastrati A, et al. J Am Coll Cardiol. 1997 Nov 15;30(6):1428-36. doi: 10.1016/s0735-1097(97)00334-3. J Am Coll Cardiol. 1997. PMID: 9362398
METHODS: All patients with successful coronary stent placement were eligible for this study unless they had had a major adverse cardiac event during the 1st 30 days after the procedure. ...Classification and regression tree analysis demonstrated that the incidence of reste …
METHODS: All patients with successful coronary stent placement were eligible for this study unless they had had a major adverse cardi …
Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement.
Schömig A, Kastrati A, Elezi S, Schühlen H, Dirschinger J, Dannegger F, Wilhelm M, Ulm K. Schömig A, et al. Circulation. 1997 Dec 2;96(11):3880-7. doi: 10.1161/01.cir.96.11.3880. Circulation. 1997. PMID: 9403611
BACKGROUND: Restenosis has been perceived as the tail end of a normal distribution of the response of the vessel to the intervention. ...The first and larger subgroup of lesions, which was less prone to restenosis, was centered around a mean value of 27% for diamete …
BACKGROUND: Restenosis has been perceived as the tail end of a normal distribution of the response of the vessel to the intervention. …
802 results
Jump to page
Feedback